Sex matters ... even for liver cells

April 21, 2015

Female liver cells, and in particular those in menopaused women, are more susceptible to adverse effects of drugs than their male counterparts, according to new research carried out by the JRC. It is well known that women are more vulnerable when it comes to drug-induced liver effects, but it's the first time it has been shown that there are differences at cellular level. The findings are striking and clinically relevant, and emphasise the importance of considering sex-based differences in human health risk assessment.

In this study, five prevalently used drugs (diclofenac, chlorpromazine, acetaminophen, verapamil, and omeprazole with caffeine as negative control) with known differences of adverse liver effects on men and on women were selected to investigate cellular reactions in liver cells taken from men and from women. Female cells were further sub-divided in pre-and postmenopausal groups to account for hormonal changes.

In spite of the short observation period of five hours due to cell lifespan, significant sex-specific differences for defined parameters were observed. Particularly striking was the observed higher susceptibility of postmenopausal female liver cells to drugs that cause widespread adverse liver effects in postmenopausal women.

Current theories cannot sufficiently explain why women in general are more sensitive than men to adverse effects of drugs. This study is a first step to investigate sex differences in the reaction of cells to chemicals. Toxicity testing has hitherto mainly been done on male individuals - animals and humans - assuming that findings in males are equally applicable to females. For experiments with cell cultures, in most cases, the sex of the cells used is not indicated in the report of the results. According to JRC scientists, further research is urgently needed in this field.

In clinical medicine, the consideration of sex-specific differences in diagnosis and treatment of many diseases is gaining acceptance. A sex-specific approach has yet to be established in toxicology.

This study pursues the objectives of the JRC managed EURL ECVAM (European Union Reference Laboratory for Alternatives to Animal Testing) to promote alternative approaches and is a good example for the use of in vitro methods for the exploration of human health relevant issues without resorting to animal studies. The study is in-line with European Commission policy to develop the gender dimension in EU research. In 2013 the Commission published the report "Gendered Innovations" demonstrating how sex and gender analysis can and should be integrated in the research process. Every cell has a sex. This simple fact has important implications that require consideration in pre-clinical research and toxicity testing.
-end-
Related links:

Sex Differences in Liver Toxicity--Do Female and Male Human Primary Hepatocytes React Differently to Toxicants In Vitro? http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0122786

European Commission (2013): Gendered Innovations - How Gender Analysis Contributes to Research Luxembourg: Publications Office of the European Union: http://bookshop.europa.eu/en/gendered-innovations-pbKINA25848/

European Commission Joint Research Centre

Related Liver Cells Articles from Brightsurf:

When malaria parasites trick liver cells to let themselves in
A new study led by Maria Manuel Mota, group leader at Instituto de Medicina Molecular, now shows that malaria parasites secrete the protein EXP2 that is required for their entry into hepatocytes.

First successful delivery of mitochondria to liver cells in animals
This experiment marks the first time researchers have ever successfully introduced mitochondria into specific cells in living animals.

New model shows how cells that cause liver cancer are created
Scientists have discovered how liver cancer spreads, but they haven't yet learned how liver cancer cells are born.

Certain liver cells may help prevent organ rejection after transplant, study finds
Mesenchymal stromal cells from fat tissue and bone marrow are widely used in therapeutic trials for their anti-inflammatory qualities, but new Mayo Clinic research finds that liver cells may be of greater value.

Encouraging normal liver cells to fight cancer
A study conducted at the VIB-KU Leuven Center for Cancer Biology discovered that healthy liver tissue surrounding a tumor activates a defence mechanism that restrains tumor growth.

One cell at a time, researchers create a blueprint of liver cells in health and disease
In every tissue throughout our bodies, various cell types are communicating and coordinating their efforts to perform vital functions and maintain health.

How hepatitis B and delta viruses establish infection of liver cells
Princeton University researchers have developed a new, scalable cell culture system that allows for detailed investigation of how host cells respond to infection with hepatitis B (HBV) and delta virus (HDV).

Radio-wave therapy proves effective against liver cancer cells
A new targeted therapy using non-thermal radio waves has been shown to block the growth of liver cancer cells anywhere in the body without damaging healthy cells, according to a study conducted by scientists at Wake Forest School of Medicine, part of Wake Forest Baptist Health.

US and Japanese researchers identify how liver cells protect against viral attacks
Researchers in Chapel Hill, N.C., and Tokyo have discovered a mechanism by which liver cells intrinsic resistance to diverse RNA viruses is regulated.

Liver, colon cancer cells thwarted by compounds derived from hops
The plant that adds flavor, color and bitterness to beer also produces a primary compound that thwarts cancer cells, and two important derivatives of the compound do as well.

Read More: Liver Cells News and Liver Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.